Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |